Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000185

Chief Executive Officer sold 4,536 shares at an average $78.49 ($356,012)

  • Chief Executive Officer acquired 4,536 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Monia Brett P Chief Executive Officer 2026-05-13 Option exercise 10b5-1 +1,316 $32.60 $42,902 243,978 D: show line 1 in the form
Monia Brett P Chief Executive Officer 2026-05-13 Sale 10b5-1 −1,316 $78.01 $102,665 242,662 D: show line 2 in the form
Monia Brett P Chief Executive Officer 2026-05-14 Option exercise 10b5-1 +3,220 $32.60 $104,972 245,882 D: show line 3 in the form
Monia Brett P Chief Executive Officer 2026-05-14 Sale 10b5-1 −3,220 $78.68 $253,347 242,662 D: show line 4 in the form
Open-market sales · 4,536 sh · avg $78.49 · $356,012

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Monia Brett P Chief Executive Officer 2026-05-13 Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −1,316 38,857 D: show line 5 in the form
Monia Brett P Chief Executive Officer 2026-05-14 Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −3,220 35,637 D: show line 6 in the form
Loading xslF345X06/edgardoc.xml…